John Copier

1.2k total citations
29 papers, 902 citations indexed

About

John Copier is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John Copier has authored 29 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in John Copier's work include Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (8 papers). John Copier is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (8 papers). John Copier collaborates with scholars based in United Kingdom, United States and Germany. John Copier's co-authors include Angus Dalgleish, Mark Bodman‐Smith, Angelo G. Scibetta, Joyce Taylor‐Papadimitriou, Joy Burchell, Daniel Fowler, Angela N. Barrett, C M Black, Christopher Bunn and Mark Walport and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

John Copier

29 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Copier United Kingdom 15 449 379 270 129 85 29 902
Anna Merlo Italy 17 254 0.6× 332 0.9× 384 1.4× 113 0.9× 75 0.9× 32 825
Shinichiro Yoshida Japan 16 709 1.6× 218 0.6× 208 0.8× 70 0.5× 184 2.2× 65 1.2k
Christophe Ronsin France 12 317 0.7× 472 1.2× 154 0.6× 134 1.0× 54 0.6× 13 925
Hamid Echchakir France 19 811 1.8× 263 0.7× 463 1.7× 122 0.9× 156 1.8× 29 1.2k
Valerie R. Wiersma Netherlands 18 564 1.3× 431 1.1× 252 0.9× 192 1.5× 47 0.6× 35 971
Elisabetta Dondi France 15 348 0.8× 218 0.6× 256 0.9× 72 0.6× 38 0.4× 34 723
Peisha Yan United States 13 289 0.6× 632 1.7× 170 0.6× 111 0.9× 35 0.4× 26 983
Manuel Schmidt Germany 14 603 1.3× 273 0.7× 353 1.3× 65 0.5× 47 0.6× 50 1.0k
Likun Du Sweden 21 495 1.1× 524 1.4× 227 0.8× 119 0.9× 63 0.7× 35 1.0k
Francesca Rini Italy 17 733 1.6× 388 1.0× 478 1.8× 81 0.6× 32 0.4× 26 1.0k

Countries citing papers authored by John Copier

Since Specialization
Citations

This map shows the geographic impact of John Copier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Copier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Copier more than expected).

Fields of papers citing papers by John Copier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Copier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Copier. The network helps show where John Copier may publish in the future.

Co-authorship network of co-authors of John Copier

This figure shows the co-authorship network connecting the top 25 collaborators of John Copier. A scholar is included among the top collaborators of John Copier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Copier. John Copier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stavrinides, Vasilis, Angus Dalgleish, John Copier, & Caroline M. Moore. (2020). Mycobacterial immunotherapy for prostate cancer: where can we go from here?. Nature Reviews Urology. 17(4). 189–190. 2 indexed citations
2.
Dalgleish, Angus, et al.. (2019). In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells. Scientific Reports. 9(1). 1544–1544. 14 indexed citations
3.
Green, Deborah M., Mark Bodman‐Smith, Katherine Bodman-Smith, et al.. (2018). Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine. Translational Oncology. 12(3). 397–403. 3 indexed citations
4.
Fowler, Daniel, John Copier, Angus Dalgleish, & Mark Bodman‐Smith. (2017). Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner. Cancer Immunology Immunotherapy. 66(9). 1205–1215. 18 indexed citations
5.
Kögel, Tanja, Rüdiger Rudolf, Erlend Hodneland, et al.. (2013). Rab3D Is Critical for Secretory Granule Maturation in PC12 Cells. PLoS ONE. 8(3). e57321–e57321. 14 indexed citations
6.
Fowler, Daniel, John Copier, Natalie Wilson, Angus Dalgleish, & Mark Bodman‐Smith. (2011). Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy. Cancer Immunology Immunotherapy. 61(4). 535–547. 44 indexed citations
7.
Copier, John, Angus Dalgleish, Cedrik M. Britten, et al.. (2009). Improving the efficacy of cancer immunotherapy. European Journal of Cancer. 45(8). 1424–1431. 35 indexed citations
8.
Copier, John, B Meyer, Mark Bodman‐Smith, et al.. (2009). T-regulatory cell modulation: the future of cancer immunotherapy?. British Journal of Cancer. 100(11). 1697–1703. 76 indexed citations
9.
Copier, John, Stephen Ward, & Angus Dalgleish. (2007). Cell based cancer vaccines: Regulatory and commercial development. Vaccine. 25. B35–B46. 27 indexed citations
10.
Scibetta, Angelo G., Samantha Santangelo, Julia Coleman, et al.. (2007). Functional Analysis of the Transcription Repressor PLU-1/JARID1B. Molecular and Cellular Biology. 27(20). 7220–7235. 100 indexed citations
11.
Copier, John & Angus Dalgleish. (2006). Overview of Tumor Cell–Based Vaccines. International Reviews of Immunology. 25(5-6). 297–319. 95 indexed citations
12.
Copier, John, Mike Whelan, & Angus Dalgleish. (2006). Biomarkers for the Development of Cancer Vaccines. Molecular Diagnosis & Therapy. 10(6). 337–343. 12 indexed citations
13.
Scibetta, Angelo G., John Copier, Angela N. Barrett, Tracy Chaplin, & Joyce Taylor‐Papadimitriou. (2005). Gene Expression Changes Induced by a Recombinant E1<sup>–</sup>/E3<sup>–</sup> Adenovirus Type 5 Vector in Human Mammary Epithelial Cells. Intervirology. 48(6). 350–361. 9 indexed citations
14.
Barrett, Angela N., Bente Kühn Madsen, John Copier, et al.. (2002). PLU‐1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: A new cancer/testis antigen?. International Journal of Cancer. 101(6). 581–588. 113 indexed citations
15.
Potter, Paul, John Copier, Steven H. Sacks, et al.. (1999). Accurate intracellular localization of HLA-DM requires correct spacing of a cytoplasmic YTPL targeting motif relative to the transmembrane domain. European Journal of Immunology. 29(12). 3936–3944. 12 indexed citations
16.
Carmichael, Paul L., John Copier, Alex So, & Robert I. Lechler. (1997). Allele-Specific Variation in the Degeneracy of Major Histocompatibility Complex (MHC) Restriction. Human Immunology. 54(1). 21–29. 7 indexed citations
17.
Ibberson, Mark, John Copier, Elena Llop, et al.. (1997). T-cell receptor variable alpha ( TCRAV) polymorphisms in European, Chinese, South American, AfroCaribbean, and Gambian populations. Immunogenetics. 47(2). 124–130. 4 indexed citations
18.
Copier, John, Monique J. Kleijmeer, Sreenivasan Ponnambalam, et al.. (1996). Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB. The Journal of Immunology. 157(3). 1017–1027. 36 indexed citations
19.
Ibberson, Mark, John Copier, & Alex So. (1995). Genomic Organization of the Human T-Cell Receptor Variable α (TCRAV) Gene Cluster. Genomics. 28(2). 131–139. 5 indexed citations
20.
Marguerie, Christopher, Christopher Bunn, John Copier, et al.. (1992). The Clinical and Immunogenetic Features of Patients with Autoantibodies to the Nucleolar Antigen PM-Scl. Medicine. 71(6). 327–336. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Merlo Breakdown of academic impact, for papers by Shinichiro Yoshida Breakdown of academic impact, for papers by Christophe Ronsin Breakdown of academic impact, for papers by Hamid Echchakir Breakdown of academic impact, for papers by Valerie R. Wiersma Breakdown of academic impact, for papers by Elisabetta Dondi Breakdown of academic impact, for papers by Peisha Yan Breakdown of academic impact, for papers by Manuel Schmidt Breakdown of academic impact, for papers by Likun Du Breakdown of academic impact, for papers by Francesca Rini
Rankless by CCL
2026